2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Contemporary vancomycin dosing schemes are designed to achieve an area under the curve (AUC) to minimum inhibitory concentration (MIC) ratio of ≥400. However, scant clinical data exist to support this target and available data relied on pharmacokinetic formulas based on daily vancomycin dose and estimated renal function (demographic pharmacokinetic model) to estimate AUCs.

          Related collections

          Author and article information

          Journal
          Clin. Infect. Dis.
          Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
          1537-6591
          1058-4838
          Sep 1 2014
          : 59
          : 5
          Affiliations
          [1 ] Albany College of Pharmacy and Health Sciences, New York.
          [2 ] Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona.
          [3 ] University at Albany, State University of New York.
          Article
          ciu398
          10.1093/cid/ciu398
          24867791
          bcdb37c2-2626-4d30-89a3-a4dd362fd8e0
          © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
          History

          MRSA; outcomes,pharmacodynamics,pharmacokinetics,vancomycin

          Comments

          Comment on this article